Related references
Note: Only part of the references are listed.Differential regulation of RhoA-mediated signaling by the TPα and TPβ isoforms of the human thromboxane A2 receptor:: Independent modulation of TPα signaling by prostacyclin and nitric oxide
Katarina Wikstroem et al.
CELLULAR SIGNALLING (2008)
Endothelial cell migration during angiogenesis
Laurent Lamalice et al.
CIRCULATION RESEARCH (2007)
The ADMA/DDAH pathway is a critical regulator of endothelial cell motility
Beata Wojciak-Stothard et al.
JOURNAL OF CELL SCIENCE (2007)
Quantification of F-2-isoprostanes as a biomarker of oxidative stress
Ginger L. Milne et al.
NATURE PROTOCOLS (2007)
Insights into oxidative stress: The isoprostanes
Paolo Montuschi et al.
CURRENT MEDICINAL CHEMISTRY (2007)
An antiangiogenic neurokinin-B/thromboxane A2 regulatory axis
Saumen Pal et al.
JOURNAL OF CELL BIOLOGY (2006)
Effect of salt on isoprostanes in salt-sensitive essential hypertension
CL Laffer et al.
HYPERTENSION (2006)
Angiogenesis in life, disease and medicine
P Carmeliet
NATURE (2005)
Oxidative mediated lipid peroxidation recapitulates proarrhythmic effects on cardiac sodium channels
K Fukuda et al.
CIRCULATION RESEARCH (2005)
Involvement of thromboxane receptor in the proatherogenic effect of isoprostane F2α-III Evidence from apolipoprotein E- and LDL receptor-deficient mice
M Tang et al.
CIRCULATION (2005)
Urinary F2-isoprostanes are not associated with increased risk of type 2 diabetes
D Il'yasova et al.
OBESITY RESEARCH (2005)
Urinary 8-iso-prostaglandin F2α as a risk marker in patients with coronary heart disease -: A matched case-control study
E Schwedhelm et al.
CIRCULATION (2004)
Isomer-specific contractile effects of a series of synthetic F2-isoprostanes on retinal and cerebral microvasculature
X Hou et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Thromboxane A2 receptor signaling inhibits vascular endothelial growth factor-induced endothelial cell differentiation and migration
AW Ashton et al.
CIRCULATION RESEARCH (2004)
A versatile in vitro assay for investigating angiogenesis of the heart
FN Kiefer et al.
EXPERIMENTAL CELL RESEARCH (2004)
Capillary rarefaction and abnormal cardiovascular reactivity in hypertension
G Ciuffetti et al.
JOURNAL OF HYPERTENSION (2003)
Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells
R Benndorf et al.
CIRCULATION RESEARCH (2003)
Improved endothelial function by the thromboxane A2 receptor antagonist S 18886 in patients with coronary artery disease treated with aspirin
L Belhassen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Selective neuromicrovascular endothelial cell death by 8-iso-prostaglandin F2α -: Possible role in ischemic brain injury
S Brault et al.
STROKE (2003)
Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase
M Takemoto et al.
CIRCULATION (2002)
Early expression of angiogenesis factors in acute myocardial ischemia and infarction.
SH Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
CEA-related cell adhesion molecule 1:: A potent angiogenic factor and a major effector of vascular endothelial growth factor
S Ergün et al.
MOLECULAR CELL (2000)
Thromboxane A2 regulation of endothelial cell migration, angiogenesis, and tumor metastasis
DT Nie et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Share Paper
